Christopher Gibson - Feb 4, 2022 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role
Chief Executive Officer, Director
Signature
/s/ Nathan Hatfield, attorney-in-fact
Stock symbol
RXRX
Transactions as of
Feb 4, 2022
Transactions value $
-$3,910
Form type
4
Date filed
2/8/2022, 08:03 PM
Previous filing
Feb 2, 2022
Next filing
Feb 24, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXRX Class A Common Stock Award $0 +208K +886.98% $0.00 232K Feb 4, 2022 Direct F1
transaction RXRX Class A Common Stock Award $0 +2.72K +1.17% $0.00 234K Feb 4, 2022 Direct F2
transaction RXRX Class A Common Stock Tax liability -$3.91K -343 -0.15% $11.40 234K Feb 4, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RXRX Stock Option (Right to Buy) Award $0 +416K $0.00 416K Feb 4, 2022 Class A Common Stock 416K $11.40 Direct F3
transaction RXRX Stock Option (Right to Buy) Award $0 +5.44K $0.00 5.44K Feb 4, 2022 Class A Common Stock 5.44K $11.40 Direct
holding RXRX Stock Option (Right to Buy) 1.47M Feb 4, 2022 Class A Common Stock 1.47M $2.47 Direct F4
holding RXRX Class B Common Stock 7.76M Feb 4, 2022 Class A Common Stock 7.76M $0.00 Direct F5
holding RXRX Class B Common Stock 550K Feb 4, 2022 Class A Common Stock 550K $0.00 by LAHWRAN-3 LLC F5, F6
holding RXRX Class B Common Stock 550K Feb 4, 2022 Class A Common Stock 550K $0.00 by LAHWRAN-4 LLC F5, F7
holding RXRX Class B Common Stock 147K Feb 4, 2022 Class A Common Stock 147K $0.00 by Gibson Family Trust F5, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This RSU vests as to one one-sixteenth (1/16th) of the units subject the RSU on May 15, 2022 and every three months thereafter.
F2 This RSU vested immediately upon the grant date.
F3 The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
F4 The option, originally for 1,500,000 shares, of which 28,646 shares have been exercised, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
F5 Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
F6 The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager.
F7 The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager.
F8 The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee.